Delving into the Latest Updates on BioNet Pharma GmbH with Synapse

概览

关联

3

项与 BioNet Pharma GmbH 相关的临床试验

NCT00519155

/ Unknown status临床2期

Pilot Study on Safety and Explorative Efficacy of MD05 in Comparison With Open Flap Debridement in Patients Undergoing Periodontal Surgery to Treat Deep Intrabony Defects

The purpose of the study is to gain experience of safety and efficacy with MD05 in man in alveolar bone regeneration.

开始日期2007-07-01

申办/合作机构

BioNet Pharma GmbH

[+1]

EUCTR2005-003391-37-DE

/ Not yet recruitingN/A

Pilot Study on Safety and explorative Efficacy of MD05 in Comparison with the Medical Device Beta-TCP Mixed with Autogenous Bone Material in Patients Undergoing Two-Stage Unilateral Maxillary Sinus Floor Augmentation - Sinus Lift Study

开始日期2005-12-05

申办/合作机构

BioNet Pharma GmbH

NCT00520377

/ Unknown status临床2期

Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation

The primary objective is the area of newly formed bone (%) as assessed by histomorphometry with either MD05 or beta-TCP.

开始日期2005-01-01

申办/合作机构

BioNet Pharma GmbH

[+1]

100 项与 BioNet Pharma GmbH 相关的临床结果